Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-18

Clinical Trial Update: Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating tranexamic acid to prevent postpartum hemorrhage after cesarean section; the current status is not stated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Shanghai First Maternity and Infant Hospital | Conditions: Postpartum Hemorrhage, Cesarean Section | Phase 4 | Status: UNKNOWN